Certification
of CEO Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002
In
connection with the Quarterly Report of BioSante Pharmaceuticals, Inc.
(the
“Company”) on Form 10-Q for the quarterly period ended September 30,
2005 as filed with the Securities and Exchange Commission on the date
hereof
(the “Report”), I, Stephen M. Simes, Vice Chairman, President and Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
to the
best of my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d)
of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material
respects,
the financial condition and results of operations of the
Company.
Date: November
14, 2005
/s/
Stephen M. Simes
Stephen
M. Simes
Vice
Chairman, President and Chief Executive Officer